×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
JNJ – johnson & johnson (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
JNJ
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/10
11:51 am
jnj
Johnson & Johnson (JNJ) had its price target raised by Morgan Stanley from $262.00 to $267.00. They now have an "overweight" rating on the stock.
Low
Report
Johnson & Johnson (JNJ) had its price target raised by Morgan Stanley from $262.00 to $267.00. They now have an "overweight" rating on the stock.
4/10
08:00 am
jnj
Johnson & Johnson Showcases New Clinical Data for TECNIS PureSee IOL at ASCRS 2026 Demonstrating Excellent Contrast Sensitivity and Extended Range of Vision
Low
Report
Johnson & Johnson Showcases New Clinical Data for TECNIS PureSee IOL at ASCRS 2026 Demonstrating Excellent Contrast Sensitivity and Extended Range of Vision
4/9
08:33 am
jnj
Johnson & Johnson PFA Launch Puts VARIPULSE Pro And Valuation In Focus [Yahoo! Finance]
Low
Report
Johnson & Johnson PFA Launch Puts VARIPULSE Pro And Valuation In Focus [Yahoo! Finance]
4/8
08:13 pm
jnj
Johnson & Johnson (JNJ) Increases Yet Falls Behind Market: What Investors Need to Know [Yahoo! Finance]
Low
Report
Johnson & Johnson (JNJ) Increases Yet Falls Behind Market: What Investors Need to Know [Yahoo! Finance]
4/8
01:51 pm
jnj
How Raw Sugar Living's CEO Is Fighting Inflation In The Beauty Aisle [Forbes]
Low
Report
How Raw Sugar Living's CEO Is Fighting Inflation In The Beauty Aisle [Forbes]
4/8
10:00 am
jnj
Johnson & Johnson (JNJ) is now covered by TD Cowen. They set a "buy" rating and a $250.00 price target on the stock.
Low
Report
Johnson & Johnson (JNJ) is now covered by TD Cowen. They set a "buy" rating and a $250.00 price target on the stock.
4/8
01:23 am
jnj
Here is Why Johnson & Johnson (JNJ) Ranks Among the 15 Best Low Volatility Blue Chip Stocks to Buy Now [Yahoo! Finance]
Low
Report
Here is Why Johnson & Johnson (JNJ) Ranks Among the 15 Best Low Volatility Blue Chip Stocks to Buy Now [Yahoo! Finance]
4/7
08:06 pm
jnj
J&J launches enhanced PFA device in Europe [Yahoo! Finance]
Low
Report
J&J launches enhanced PFA device in Europe [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/26
10:05 am
jnj
Form SCHEDULE 13G/A JOHNSON & JOHNSON Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G/A JOHNSON & JOHNSON Filed by: VANGUARD GROUP INC
3/18
11:57 am
jnj
Form 13F-HR/A JOHNSON & JOHNSON For: Dec 31
Low
Report
Form 13F-HR/A JOHNSON & JOHNSON For: Dec 31
3/18
11:38 am
jnj
Form 13F-HR/A JOHNSON & JOHNSON For: Sep 30
Low
Report
Form 13F-HR/A JOHNSON & JOHNSON For: Sep 30
3/12
09:31 pm
jnj
Form 4 JOHNSON & JOHNSON For: Mar 04 Filed by: HEWSON MARILLYN A
Low
Report
Form 4 JOHNSON & JOHNSON For: Mar 04 Filed by: HEWSON MARILLYN A
3/12
08:40 pm
jnj
Form 4 JOHNSON & JOHNSON For: Mar 10 Filed by: Pinto Daniel E
Low
Report
Form 4 JOHNSON & JOHNSON For: Mar 10 Filed by: Pinto Daniel E
3/12
08:37 pm
jnj
Form 4 JOHNSON & JOHNSON For: Mar 10 Filed by: Woods Eugene A.
Low
Report
Form 4 JOHNSON & JOHNSON For: Mar 10 Filed by: Woods Eugene A.
3/11
06:23 am
jnj
Form ARS JOHNSON & JOHNSON For: Dec 28
Low
Report
Form ARS JOHNSON & JOHNSON For: Dec 28
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/27
Form DEFA14A JOHNSON & JOHNSON
8.1%
3/12 Paul Harris' Top Picks: March 12, 2020 [Business News Network (BNN) Energy & Resources (Canada)] 7.5%
4/7 Is JNJ Stock A Buy On CEO's Bullish Call For Coronavirus Vaccine? [Investor's Business Daily] 4.6%
4/5 Will These 3 Coronavirus Stocks Lead the Market to Recovery? [Yahoo! Finance News] 4.3%
4/13 Stocks slip as market enters new phase, with investors worrying about balance sheets [CNBC] 4.0%
3/2 AODocs Joins AIIM Leadership Council, Showcases Innovative Approach to Information Management at 2020 AIIM Conference 3.9%
3/4 Johnson & Johnson ordered to pay $1.7 million to three Australian women in pelvic mesh class action [Reuters] 3.8%
3/18 Is This 1 Healthcare Stock Coronavirus-Proof? [The Motley Fool] 3.8%
3/24 What Technology And Manufacturing Can Do To Help Against COVID-19 [Forbes] 3.6%
4/1 5 of the Best Stocks to Buy for April [Yahoo! Finance News] 3.3%
3/12 Paul Harris' Top Picks: March 12, 2020 [Business News Network (BNN) Energy & Resources (Canada)] 7.5%
4/7 Is JNJ Stock A Buy On CEO's Bullish Call For Coronavirus Vaccine? [Investor's Business Daily] 4.6%
4/5 Will These 3 Coronavirus Stocks Lead the Market to Recovery? [Yahoo! Finance News] 4.3%
4/13 Stocks slip as market enters new phase, with investors worrying about balance sheets [CNBC] 4.0%
3/2 AODocs Joins AIIM Leadership Council, Showcases Innovative Approach to Information Management at 2020 AIIM Conference 3.9%
3/4 Johnson & Johnson ordered to pay $1.7 million to three Australian women in pelvic mesh class action [Reuters] 3.8%
3/18 Is This 1 Healthcare Stock Coronavirus-Proof? [The Motley Fool] 3.8%
3/24 What Technology And Manufacturing Can Do To Help Against COVID-19 [Forbes] 3.6%
4/1 5 of the Best Stocks to Buy for April [Yahoo! Finance News] 3.3%
TOP News Decliners
3/21
Johnson and Johnson: A Safe Haven in Recession [The Motley Fool]
-7.3%
3/20 Is Johnson & Johnson (NYSE:JNJ) Trading At A 35% Discount? [Yahoo! Finance News] -6.9%
3/10 J&J MET antibody nabs accelerated review status for certain lung cancer patients [Seeking Alpha] -6.8%
3/18 J&J files U.S. application for MS med ponesimod [Seeking Alpha] -6.6%
10/18 Wolves In Sheep’s Clothing: We Can’t Trust Businesses To Do Right By Americans Now [Forbes] -6.4%
5/28 Oklahoma taking on Johnson & Johnson in historic trial [MSNBC.com] -6.1%
3/13 Americans rush to stock up on essentials as coronavirus spreads [Reuters] -5.5%
3/11 Desperate to exit, a $10B price tag for Magic Leap is crazy [TechCrunch Blog] -4.9%
7/12 Johnson & Johnson (NYSE: JNJ) is now covered by analysts at Credit Suisse Group AG. They set an "outperform" rating and a $156.00 price target on the stock. -4.5%
3/6 Eyecare industry leaders sign Proclamation to focus on key issues facing the future of optometry -3.8%
3/20 Is Johnson & Johnson (NYSE:JNJ) Trading At A 35% Discount? [Yahoo! Finance News] -6.9%
3/10 J&J MET antibody nabs accelerated review status for certain lung cancer patients [Seeking Alpha] -6.8%
3/18 J&J files U.S. application for MS med ponesimod [Seeking Alpha] -6.6%
10/18 Wolves In Sheep’s Clothing: We Can’t Trust Businesses To Do Right By Americans Now [Forbes] -6.4%
5/28 Oklahoma taking on Johnson & Johnson in historic trial [MSNBC.com] -6.1%
3/13 Americans rush to stock up on essentials as coronavirus spreads [Reuters] -5.5%
3/11 Desperate to exit, a $10B price tag for Magic Leap is crazy [TechCrunch Blog] -4.9%
7/12 Johnson & Johnson (NYSE: JNJ) is now covered by analysts at Credit Suisse Group AG. They set an "outperform" rating and a $156.00 price target on the stock. -4.5%
3/6 Eyecare industry leaders sign Proclamation to focus on key issues facing the future of optometry -3.8%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: